4//SEC Filing
INTERLEUKIN GENETICS INC 4
Accession 0001144204-17-004094
CIK 0001037649operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:56 PM ET
Size
5.6 KB
Accession
0001144204-17-004094
Insider Transaction Report
Form 4
Toutain Stephan
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-25+365,093→ 365,093 totalExercise: $0.12Exp: 2027-01-25→ Common Stock (365,093 underlying)
Footnotes (2)
- [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option.
- [F2]The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018.
Documents
Issuer
INTERLEUKIN GENETICS INC
CIK 0001037649
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001037649
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:56 PM ET
- Size
- 5.6 KB